Xeris Biopharma Holdings Inc (XERS)
Operating Cash Flow Growth
449.89%
TTM · Period ending:
XERS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported449.89%period ending
Latest reported449.89%period ending
XERS TTM Cash from Operations YoY % (-128.19% → 449.89%)
Year-over-year change
High-resolution chart · PNG
XERS operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 449.8857% | |
| 281.6878% | |
| 177.4073% | |
| 132.3171% | |
| 58.4888% | |
| 36.964% | |
| 23.2887% | |
| 53.7337% | |
| 47.1576% | |
| 47.4449% | |
| 53.1465% | |
| 38.9784% | |
| 38.8289% | |
| 32.8083% | |
| -7.6998% | |
| -49.3945% | |
| -67.8569% | |
| -58.7794% | |
| -18.5916% | |
| 21.9653% | |
| 36.3524% | |
| 32.6101% | |
| 22.7972% | |
| -6.6073% | |
| -43.8739% | |
| -61.0516% | |
| -85.4084% | |
| -97.919% | |
| -113.7179% | |
| -140.5195% | |
| -128.192% |